Singapore markets closed
Straits Times Index
3,338.94 -9.93 (-0.30%) S&P 500
5,267.95 -15.45 (-0.29%) Dow
38,561.97 -9.06 (-0.02%) Nasdaq
16,774.62 -54.05 (-0.32%) Bitcoin USD
69,685.48 +788.10 (+1.14%) CMC Crypto 200
1,453.41 +6.26 (+0.43%)
Boston Scientific Corp (BSX.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
As of 02:45PM CEST. Market open.
| Previous close | 68.50 |
| Open | 69.00 |
| Bid | 69.50 x 60000 |
| Ask | 70.00 x 100000 |
| Day's range | 69.00 - 70.00 |
| 52-week range | 45.72 - 70.50 |
| Volume | |
| Avg. volume | 168 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 25 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksInari's (NARI) Expanding Product Portfolio Offsets Competition
Inari's (NARI) VTE products are driving its top line on the back of robust adoption. The company is expanding in additional indications to fuel growth and fight competition.
ZacksHere's Why You Should Retain Glaukos (GKOS) Stock for Now
Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.
ZacksThree Reasons to Retain BD (BDX) Stock in Your Portfolio Now
BD's (BDX) robust product portfolio raises optimism about the stock.
© 2024 Yahoo. All rights reserved.